Mayorga Ayala, L.; Herrera-deGuise, C.; Esperalba, J.; Martinez-Gomez, X.; Céspedes Martinez, E.; Serra Ruiz, X.; Robles, V.; Lastiri, E.; Perez, Z.; Oller, E.;
et al. Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients. Cells 2025, 14, 1156.
https://doi.org/10.3390/cells14151156
AMA Style
Mayorga Ayala L, Herrera-deGuise C, Esperalba J, Martinez-Gomez X, Céspedes Martinez E, Serra Ruiz X, Robles V, Lastiri E, Perez Z, Oller E,
et al. Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients. Cells. 2025; 14(15):1156.
https://doi.org/10.3390/cells14151156
Chicago/Turabian Style
Mayorga Ayala, Luis, Claudia Herrera-deGuise, Juliana Esperalba, Xavier Martinez-Gomez, Elena Céspedes Martinez, Xavier Serra Ruiz, Virginia Robles, Ernesto Lastiri, Zahira Perez, Elena Oller,
and et al. 2025. "Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients" Cells 14, no. 15: 1156.
https://doi.org/10.3390/cells14151156
APA Style
Mayorga Ayala, L., Herrera-deGuise, C., Esperalba, J., Martinez-Gomez, X., Céspedes Martinez, E., Serra Ruiz, X., Robles, V., Lastiri, E., Perez, Z., Oller, E., Fernandez-Naval, C., Martinez-Gallo, M., Casellas, F., & Borruel, N.
(2025). Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients. Cells, 14(15), 1156.
https://doi.org/10.3390/cells14151156
